Skip to content

13F-HR filed by SCOPIA CAPITAL MANAGEMENT LP

SCOPIA CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 24 holding rows worth $2,707,400,000.

Accession
0000891092-19-005831
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 24 entries on the cover page, a total value of $2,707,400,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,707,400,000 with VALUE read as thousands by filing date, 13F file number 028-11096. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VISTRA CORP COM92840M102Stock13,230,577$344,392,000thousands by filing date
JOHNSON CTLS INTL PLC SHSG51502105Stock6,893,643$254,651,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR7,207,601$217,309,000thousands by filing date
ITRON INC COM465741106Stock4,624,932$215,753,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS8,159,184$215,647,000thousands by filing date
SPIRIT AEROSYSTEMS HLDGS INC848574109COM CL A2,280,283$208,714,000thousands by filing date
EQUITRANS MIDSTREAM CORP NPV294600101COM8,343,608$181,724,000thousands by filing date
SPY78462F103SHS542,100$153,132,000thousands by filing dateput
GW PHARMACEUTICALS PLC36197T103ADS749,538$126,350,000thousands by filing date
ZOGENIX INC.98978L204Common Stock1,910,753$105,111,000thousands by filing date
SPIRIT RLTY CAP INC NEW NPV84860W300COM NEW2,583,473$102,641,000thousands by filing date
RETROPHIN INC761299106COM4,214,972$95,385,000thousands by filing date
VONAGE HLDGS CORP92886T201COM8,664,115$86,988,000thousands by filing date
INVESTORS BANCORP, INC.46146L101COMMON STOCK7,224,672$85,612,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM2,106,190$79,277,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM4,460,073$59,274,000thousands by filing date
OPENLANE INC48238T109COM1,051,894$53,973,000thousands by filing date
IMMUNOMEDICS INC452907108COM1,937,843$37,226,000thousands by filing date
WELBILT INC949090104COM2,069,997$33,907,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock920,282$24,121,000thousands by filing date
HARMONIC INC413160102COM2,877,593$15,597,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock600,000$7,278,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2480,000$3,086,000thousands by filing date
AMERICAN SUPERCONDUCTOR CORP030111207SHS NEW19,610$252,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000891092-19-005831this filing2019-05-15acceptance time not in the bulk data set